Jotair L Kid Syrup is a pediatric formulation combining Levocetirizine (2.5mg/5ml) and Montelukast (4mg/5ml), designed to provide effective relief from allergic conditions in children. Levocetirizine, a selective second-generation antihistamine, acts by inhibiting peripheral H1 receptors, thereby reducing symptoms such as sneezing, rhinorrhea, itching, and urticaria associated with allergic rhinitis and chronic urticaria. Montelukast, a leukotriene receptor antagonist, blocks cysteinyl leukotriene receptors, preventing bronchoconstriction and inflammation, which are key contributors to asthma and allergic rhinitis pathophysiology. The synergistic combination of these two agents offers comprehensive management of allergic symptoms, improving respiratory function and overall quality of life in pediatric patients. Jotair L Kid Syrup is indicated for the treatment of allergic rhinitis, chronic urticaria, and mild to moderate asthma in children. It is generally well tolerated, with a favorable safety profile; common adverse effects may include headache, drowsiness, or gastrointestinal discomfort. Dosage should be administered as per pediatrician’s recommendation, considering the child’s age and clinical condition. This combination therapy provides a convenient and effective approach for managing multiple allergic manifestations in children, ensuring better compliance and symptom control.